Tachyon Ventures — Full Portfolio

AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry.

AI & Machine LearningBiotechDeep TechAndover, US

Chris Bahl(Executive Officer, Director)Dominique Verhelle(Director)Bill McKee(Director)Julia Novina(Executive Officer)Marc A. Cohen(Executive Officer, Director)inGeoff Meyerson(Director)

Co-investorsMission BiocapitalCobro Ventures

Altay Therapeutics develops small molecule inhibitors targeting transcription factors to treat serious diseases including facioscapulohumeral muscular dystrophy and cancer.

BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Ali Ozes(Founder)inOsman Ozes(Founder)in

Co-investorsCreative Destruction Lab (CDL)Y Combinator

Axonis Therapeutics is a drug discovery company developing first-in-class therapies for currently incurable neurological disorders.

BiotechDeep TechHealthtechMedical DevicesBoston, US

Shane Hegarty(Executive Officer)Shane V. Hegarty(Chief Scientific Officer & Co-Founder)Jeffrey Imbaro(Executive Officer)Joanna Stanicka(Chief Executive Officer, President & Co-Founder)Jeff Imbaro(Chief Operating Officer)Tiasha Shafiq(Chief of Staff)

Co-investorsCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture PartnersIaso VenturesLumira VenturesPathway Bioventures+6 more

BiotechBerkeley, US

Genine A. Winslow(Executive Officer, Director)Ran Geng(Director)Winnie Wan(Director)

Co-investorsBerkeley SkyDeck FundFuture Planet CapitalSolasta Ventures

EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.

BiotechDigital HealthHealthtechMedical DevicesCambridge, US

Anthony DePasqua(Executive Officer, Director)inJason Camm(Director)Kasper Roet(Director)Tony DePasqua(President & CEO)Kevin Kalish(COO)Marcie Glicksman(VP Biology)

Co-investors20/20 HealthCare Partners LLCFlucas VenturesVU Venture PartnersDolby Family Ventures

EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.

BiotechHealthtechMedical DevicesNew York, US

Nina Tandon(Co-Founder, CEO)Sarindr Bhumiratana(Co-Founder)Gordana Vunjak-Novakovic(Director)Elma Hawkins(Director)

BoardRobert Langer(Director)David Zhu(Director)

Co-investorsBeresford VenturesEMV CapitalHackensack Meridian Health Bear's DenKendall Capital PartnersPlum Alley InvestmentsTech Council Ventures

Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases, with an initial focus on platelet-inspired treatments for active bleeding and bleeding risks from trauma, surgery, thrombocytopenia, and rare bleeding disorders.

BiotechMedical Devices

Anirban Sen Gupta(CTO)Michael Bruckman(CEO)Matthew Neal(CMO)Christa Pawlowski(COO and EVP of R&D)Timothy Pelura(Executive Chair)

Co-investorsCWRU Technology Ventures

Mammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.

BiotechDeep TechMedical DevicesBrisbane, US

Jennifer Doudna(Founder)inTrevor Martin(Co-founder, Chief Executive Officer)inJanice Chen(Co-founder, Chief Scientific Officer & President, Research)inLucas Harrington(Co-founder)inAshley Tehranchi(Executive Officer, Director)

BoardUrshit Parikh(Director)

Co-investors8VCBerkeley FrontierCALIFORNIA INNOVATIONDecheng CapitalForesite CapitalMayfield Fund+9 more

miRecule is a biotechnology company developing therapeutics, with programs focused on oncology.

BiotechHealthtechGaithersburg, US

Anthony Saleh(Executive Officer)Anthony D. Saleh(CEO)Dave Lemus(COO/CFO)

Co-investorsBrown and White VenturesPathway Bioventures

Palm Therapeutics develops palmitoylation-targeted drugs using its proprietary PalmReader screening platform to identify novel therapeutic molecules.

BiotechDeep TechMedical Devices

Andrew Rudd(Cofounder & CEO)

Peptilogics is a clinical-stage surgical therapeutics company developing zaloganan (PLG0206), a novel anti-biofilm drug to treat and prevent medical device-related infections such as prosthetic joint infections.

BiotechHealthtechMedical DevicesPittsburg, US

Jonathan Steckbeck(Executive Officer, Director)

BoardStephan Dietrich(Director)in

Co-investorsAAF Management Ltd.Alpha Wave GlobalAMR Action FundMountain State CapitalNarya CapitalRiverfront Ventures, LLC+2 more

Co-investorsBoston Harbor Angels

Scipher Medicine is a precision immunology company that uses molecular blood tests, such as PrismRA, to match patients with the most effective therapy for autoimmune diseases like rheumatoid arthritis.

AI & Machine LearningBiotechDigital Health

Joseph Loscalzo(Founder | Physician-in-Chief, Brigham and Women's Hospital)Albert-László Barabási(Founder | Professor, Harvard and Northeastern University)

Co-investorsaMoonKhosla VenturesB3 HoldingCobalt VenturesEcho Health VenturesHitachi Ventures+1 more

Stylus Medicine develops in vivo genetic medicines using engineered recombinases, with initial focus on creating CAR-T therapies delivered via lipid nanoparticles for oncology, autoimmune, and genetic diseases.

BiotechDigital HealthMedical Devices

Michael C. Bassik, Ph.D.(Scientific Founder)inEmile Nuwaysir, Ph.D.(Chairman & Chief Executive Officer)inJason Fontenot, Ph.D.(Chief Scientific Officer)

Co-investorsBrainstorm VenturesKhosla VenturesNeva Sgr.RA Capital

Valo builds an AI-driven drug discovery and development platform that combines real-world human data, causal inference, statistical genetics, and predictive chemistry to identify disease targets and engineer small-molecule compounds.

AI & Machine LearningBiotechDeep Tech

Co-investorsLifeforce Capital

BiotechHealthtech

Co-investorsClal Biotechnology IndustriesExSight VenturesLongitude CapitalThe Column Group